Intravenous Thrombolysis in Acute Ischemic Stroke: Experiences in Dokuz Eylül University Hospital, Medical Faculty, Department of Neurology
Journal Title: Journal of Neurological Sciences-Turkish - Year 2008, Vol 25, Issue 2
Abstract
Acute stroke is the second leading cause of death after heart diseases in the world. Acute ischemic stroke (AIS) accounts for 80% of all strokes. The idea that AIS is an incurable disease has been abolished during the recent years because of thrombolytic treatment. To date, the only proven therapy in acute ischemic stroke to prevent infarction and minimize the degree of permanent brain injury is thrombolytic treatment. But it has some limitations; it has narrow theuropatic index and high risk of serious complications and also well-established stroke centers are needed for this therapy. We present 21 patients with acute ischemic stroke (13 male, 8 female) who were treated with intravenous recombinant tissue plasminogen activator (IV rt-PA) in our department between 19.09.2006 – 30.01.2008. The neurological statuses of the patients were assessed by “The National Institutes of Health Stroke Scale” (NIHSS) before thrombolysis application, at 24 hour, at 1 week and at 3 months. At the first day of the therapy, 75% of patients had excellent global outcomes (minimal or no deficit). The neurological examinations of IV rt-PA patients at 1 month and at 3 months were also excellent. Symptomatic intracranial bleeding was occured in one patient as a result of IV rt-PA threapy. Four patients were died, one patient died because of brain edema without hemorrhage, one patient died because of brain hemorrhage, the others died because of systemic reasons. Despite low number of patients, our experience contributed important information that IV rt-PA treatment is effective and reliable in well-selected patients.
Authors and Affiliations
Vesile OZTURK, Erdem YAKA, Burcu UGUREL, Turan POYRAZ, Suleyman MEN, Kursat KUTLUK
Keywords
Related Articles
- EP ID EP96700
- DOI -
- Views 87
- Downloads 0
Clinical and Electrodiagnostic findings of n-Hexane Neuropathy
n-Hexane is an isomer of hexane and was identified as a peripheral neurotoxin in 1964. The solvents containing n-Hexane are used as cleaning agents in the printing, textile, furniture and shoemaking industries. Certain k...
Ataxic gait due to Giant Cystic Virchow-Robin Spaces: Case Report
Virchow-Robin spaces (VRSs) are perivascular pia-lined extensions of the subarachnoid space around the arteries and veins as they enter the brain parenchyma. The precise etiology of these enlarged perivascular spaces (PV...
Succinic Semialdehyde Dehydrogenase Deficiency : Three Sibling in A Family (Case Report)
Succinic semialdehyde dehydrogenase enzyme (SSADH) deficiency is a rare autosomal disorder involving the catabolism of the neurotransmitter γ-amino butyric acid (GABA). In the absence of SSADH, GABA is converted to 4-hyd...
Adie's Tonic Pupil and Anti-Ganglioside IgG Antibodies
Objective: The presence of anti-ganglioside IgG antibodies has been reported in the Guillain-Barre Syndrome (GBS) and the Miller-Fisher Syndrome (MFS). Adie's tonic pupil (ATP) is similar to GBS and its variants wi...
Subaraknoid Kanamayı Taklit Eden Servikal Epidural Abse: Atipik Bir Olgu Sunumu
Spinal epidural absede geç tanı kötü prognozla sonuçlanır. Bu olgu tipik olmayan bir spinal epidural abseyi öne çıkarmaktadır. Erken tanı erken tedavi ve dolayısı ile iyi sonuç demektir. Klinik öykü ve BOS bulguları ile...